Cytek Biosciences, Inc.
NASDAQ:CTKB
6.83 (USD) • At close January 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Operating Activities: | |||||
Net Income
| -12.148 | 2.484 | 3.027 | 19.411 | -16.827 |
Depreciation & Amortization
| 9.23 | 5.659 | 1.242 | 0.603 | 0.309 |
Deferred Income Tax
| 0 | 0 | 0.448 | 1.744 | 0 |
Stock Based Compensation
| 22.048 | 16.595 | 6.586 | 0.611 | 0.269 |
Change In Working Capital
| -10.509 | -39.928 | -8.646 | -7.536 | 1.158 |
Accounts Receivables
| -7.332 | -19.744 | -12.367 | 0.334 | -12.612 |
Inventory
| 4.286 | -17.653 | -7.068 | -5.704 | -14.614 |
Accounts Payables
| -1.784 | 1.862 | -0.256 | -0.055 | 1.213 |
Other Working Capital
| -5.679 | -4.393 | 11.045 | -2.111 | 27.171 |
Other Non Cash Items
| -3.34 | 2.959 | 1.973 | 0.323 | 1.344 |
Operating Cash Flow
| 5.281 | -12.231 | 4.63 | 15.156 | -13.747 |
Investing Activities: | |||||
Investments In Property Plant And Equipment
| -4.648 | -9.868 | -4.364 | -1.547 | -0.973 |
Acquisitions Net
| -45.132 | 0 | -16.629 | 0 | 0 |
Purchases Of Investments
| -175.935 | -46.041 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 132 | 0 | 0 | 0 | 0 |
Other Investing Activites
| -0.179 | -46.161 | 0.371 | 0 | 0 |
Investing Cash Flow
| -93.894 | -55.909 | -20.993 | -1.547 | -0.973 |
Financing Activities: | |||||
Debt Repayment
| -0.565 | 2.933 | 0 | 2.772 | 0 |
Common Stock Issued
| 0 | 1.204 | 215.689 | 119.835 | 0.093 |
Common Stock Repurchased
| -44.151 | -0.209 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 2.904 | 2.58 | 213.559 | 239.501 | 0.093 |
Financing Cash Flow
| -41.812 | 5.513 | 213.559 | 122.607 | 0.093 |
Other Information: | |||||
Effect Of Forex Changes On Cash
| -1.445 | -2.491 | 1.303 | -0.587 | -0.033 |
Net Change In Cash
| -131.87 | -65.118 | 198.499 | 135.629 | -14.66 |
Cash At End Of Period
| 167.63 | 299.5 | 364.618 | 166.119 | 30.49 |